Literature DB >> 21494279

Qualitative and quantitative OCT response of diffuse diabetic macular oedema to macular laser photocoagulation.

R Vemala1, S Koshy, S Sivaprasad.   

Abstract

PURPOSE: To assess the quantitative and morphological changes of the macula in response to macular grid laser for diabetic macular oedema (DMO) using optical coherence tomography (OCT). PATIENTS AND METHODS: Cirrus OCT macular cube scans of 30 eyes of 25 patients were retrospectively analysed before and 4 months after macular grid laser for diffuse DMO. The oedema was quantified and response evaluated in the nine early-treatment diabetic retinopathy study (ETDRS) zones of the macula. Post-laser OCT changes were compared with the baseline features, including morphology patterns, changes in both logarithmic transformed (logOCT) and standardised average macular thickness (AMT), total macular volume, number of parafoveal quadrants involved, and the presence of intact 3rd hyper-reflective band (HRB).
RESULTS: The rate of change of retinal thickness in response to laser was maximum in the central (8.17%) and perifoveal inferior quadrants (0.04%). Diffuse retinal thickening on OCT responded best to treatment. The AMT of 300-350 μm had the worst response (+0.94%). Eyes with less than four quadrants of oedema showed good response. Disrupted HRB was associated with poor visual gain (-0.33 ETDRS letters).
CONCLUSION: The topographic location of oedema on the retinal map and the morphological patterns of the oedema on OCT are useful predictors of treatment response in diffuse DMO.

Entities:  

Mesh:

Year:  2011        PMID: 21494279      PMCID: PMC3171792          DOI: 10.1038/eye.2011.84

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  39 in total

1.  The association between visual acuity and central retinal thickness in retinitis pigmentosa.

Authors:  Michael A Sandberg; Robert J Brockhurst; Alexander R Gaudio; Eliot L Berson
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-09       Impact factor: 4.799

2.  Photoreceptor status after resolved macular edema in branch retinal vein occlusion treated with tissue plasminogen activator.

Authors:  Tomoaki Murakami; Akitaka Tsujikawa; Masafumi Ohta; Kazuaki Miyamoto; Mihori Kita; Daiseke Watanabe; Hitoshi Takagi; Nagahisa Yoshimura
Journal:  Am J Ophthalmol       Date:  2006-09-28       Impact factor: 5.258

3.  Characterization of epiretinal membranes using optical coherence tomography.

Authors:  J R Wilkins; C A Puliafito; M R Hee; J S Duker; E Reichel; J G Coker; J S Schuman; E A Swanson; J G Fujimoto
Journal:  Ophthalmology       Date:  1996-12       Impact factor: 12.079

4.  Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema.

Authors:  Hakan Ozdemir; Murat Karacorlu; Serra Arf Karacorlu
Journal:  Am J Ophthalmol       Date:  2005-08       Impact factor: 5.258

5.  A standardized method for reporting changes in macular thickening using optical coherence tomography.

Authors:  Annie Chan; Jay S Duker
Journal:  Arch Ophthalmol       Date:  2005-07

6.  Regional patterns of sight-threatening diabetic macular edema.

Authors:  David J Browning; Christina M Fraser
Journal:  Am J Ophthalmol       Date:  2005-07       Impact factor: 5.258

7.  Exaggerated relative nasal-temporal asymmetry of macular capillary blood flow in patients with clinically significant diabetic macular oedema.

Authors:  C Hudson; J G Flanagan; G S Turner; H C Chen; M H Rawji; D McLeod
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

8.  Histologic correlation of in vivo optical coherence tomography images of the human retina.

Authors:  Teresa C Chen; Barry Cense; Joan W Miller; Peter A D Rubin; Daniel G Deschler; Evangelos S Gragoudas; Johannes F de Boer
Journal:  Am J Ophthalmol       Date:  2006-06       Impact factor: 5.258

9.  Assessment of central visual function in Stargardt's disease/fundus flavimaculatus with ultrahigh-resolution optical coherence tomography.

Authors:  Erdem Ergun; Boris Hermann; Matthias Wirtitsch; Angelika Unterhuber; Tony H Ko; Harald Sattmann; Christoph Scholda; James G Fujimoto; Michael Stur; Wolfgang Drexler
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-01       Impact factor: 4.799

10.  Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results.

Authors:  C M Lee; R J Olk
Journal:  Ophthalmology       Date:  1991-10       Impact factor: 12.079

View more
  6 in total

1.  Importance of 3-D image reconstruction of spectral-domain OCT on outcome of grid laser photocoagulation for diffuse diabetic macular edema.

Authors:  Avinoam Ophir; Rana Hanna; Michael R Martinez
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

2.  Fluorescein angiography versus optical coherence tomography-guided planning for macular laser photocoagulation in diabetic macular edema.

Authors:  Igor Kozak; Sharif Y El-Emam; Lingyun Cheng; Dirk-Uwe Bartsch; Jay Chhablani; William R Freeman; J Fernando Arevalo
Journal:  Retina       Date:  2014-08       Impact factor: 4.256

3.  Bridging the resources gap: deep learning for fluorescein angiography and optical coherence tomography macular thickness map image translation.

Authors:  Hazem Abdelmotaal; Mohamed Sharaf; Wael Soliman; Ehab Wasfi; Salma M Kedwany
Journal:  BMC Ophthalmol       Date:  2022-09-01       Impact factor: 2.086

4.  Central macular thickness in patients with type 2 diabetes mellitus without clinical retinopathy.

Authors:  Mehmet Demir; Ersin Oba; Burcu Dirim; Erhan Ozdal; Efe Can
Journal:  BMC Ophthalmol       Date:  2013-04-09       Impact factor: 2.209

5.  Cental Macular Thickness in Patients with Type 2 Diabetes Mellitus without Clinical Retinopathy.

Authors:  Mehmet Demir; Burcu Dirim; Zeynep Acar; Murat Yılmaz; Yekta Sendul
Journal:  J Ophthalmol       Date:  2013-04-03       Impact factor: 1.909

6.  Focal laser photocoagulation in non-center involved diabetic macular edema.

Authors:  Irfan Perente; Zeynep Alkin; Abdullah Ozkaya; Doukas Dardabounis; Tulin Aras Ogreden; Aristeidis Konstantinidis; Konstantinos Kyratzoglou; Ahmet Taylan Yazici
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2014
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.